Table 2. High-risk patients with an indication for an AEP in accordance with AHA guidelines (5) and absolute and relative frequencies in the study population.
| Cardiac condition | Absolute frequency | Relative frequency (%) |
|---|---|---|
| Prosthetic cardiac valve or prosthetic material used for cardiac valve repair | 23 | 20.5 |
| Previous IE | 4 | 3.6 |
| Previous IE in patients with prosthetic cardiac valve or prosthetic material | 3 | 2.7 |
| Uncorrected cyanotic CHD | 2 | 1.8 |
| Palliative shunt or conduit | 9 | 8.0 |
| Residual defects of prosthetic material inhibiting its endothelialization | 7 | 6.3 |
| Less than 6 months after interventional or cardiothoracic procedure with implantation of foreign material | 4 | 3.6 |
| Cardiac transplantation with cardiac valvulopathy | 0 | 0 |
AEP, antibiotic endocarditis prophylaxis; CHD, congenital heart disease; AHA, American Heart Association; IE, infective endocarditis.